The Molecular Taxonomy of Primary Prostate Cancer
2015 · Cell · 3,177 citations
https://doi.org/10.1016/j.cell.2015.10.025
S
Shalini S. Yadav
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
328
Papers
8.2K
Citations
32
h-index
44
i10-index
Shalini S. Yadav is an academic researcher from The University of Texas MD Anderson Cancer Center. The author has contributed to research in topics: Viral Infections and Immunology Research & Cancer Immunotherapy and Biomarkers & Prostate Cancer Treatment and Research. The author has an h-index of 32, co-authored 279 publications.
ORCID: 0000-0001-8266-5548Papers by this author
worksNeoadjuvant chemotherapy plus nivolumab with or without ipilimumab in operable non-small cell lung cancer: the phase 2 platform NEOSTAR trial
2023 · Nature Medicine · 193 citations
https://doi.org/10.1038/s41591-022-02189-0
Hypomethylating agents in combination with immune checkpoint inhibitors in acute myeloid leukemia and myelodysplastic syndromes
2018 · Leukemia · 174 citations
https://doi.org/10.1038/s41375-018-0070-8
<i>ARID1A</i> mutation plus CXCL13 expression act as combinatorial biomarkers to predict responses to immune checkpoint therapy in mUCC
2020 · Science Translational Medicine · 125 citations
https://doi.org/10.1126/scitranslmed.abc4220
Pilot study of Tremelimumab with and without cryoablation in patients with metastatic renal cell carcinoma
2021 · Nature Communications · 60 citations
https://doi.org/10.1038/s41467-021-26415-4
Combined CTLA-4 and PD-L1 blockade in patients with chemotherapy-naïve metastatic castration-resistant prostate cancer is associated with increased myeloid and neutrophil immune subsets in the bone microenvironment
2021 · Journal for ImmunoTherapy of Cancer · 55 citations
https://doi.org/10.1136/jitc-2021-002919
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat